Novavax. A Day Late and a Dollar Short.
The US may finally get an alternative to mRNA covid vaccines...a bit too late.
Novavax is finally seeking FDA approval for its covid vaccine. The problem is, the vaccine is based off the original viral spike protein. All the trials were completed prior to Omicron. From the Epoch Times:
NVX-CoV2373 showed a “reassuring safety profile” in results from two large Phase 3 clinical trials, with an overall efficacy of about 90 percent, th…